Yuki Yoshino

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Transcription Factor

Endoplasmic Reticulum Stress

Top Venues

Cancer research communications

Molecular cancer research : MCR

Scientific reports

Tohoku University, Institute of Development, Aging, and Cancer

Institute of Development, Aging and Cancer, Tohoku University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tohoku University, Institute of Development, Aging, and Cancer Sep 01 2015

Japan

Assistant Professor :: Dept. of Cancer Biology

Institute of Development, Aging and Cancer, Tohoku University Apr 01 2015 - Aug 31 2015

Japan

Research associate :: Dept. of Cancer Biology

Education History

Institute of Development, Aging and Cancer, Tohoku University Apr 01 2011 - Mar 25 2015

Japan

PHD :: Dept. of Clinical Oncology

Tohoku University Apr 01 2003 - Mar 31 2009

Japan

PHD :: School of Medicine

Publications

Shino Endo, Yuki Yoshino, Matsuyuki Shirota, Gou Watanabe, Natsuko Chiba
BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin. Cancer research communications 1 (2) (2021)
Shino Endo, Yuki Yoshino, Matsuyuki Shirota, Gou Watanabe, Natsuko Chiba
BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin. Cancer research communications 1 (2) (2021)
Yuki Yoshino, Shino Endo, Zhenghao Chen, Huicheng Qi, Gou Watanabe, Natsuko Chiba
Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency. Scientific reports 9 (1) (2019)
Yuki Yoshino, Huicheng Qi, Hiroki Fujita, Matsuyuki Shirota, Shun Abe, Yuhei Komiyama, Kazuha Shindo, Masahiro Nakayama, Ayako Matsuzawa, Akihiro Kobayashi, Honami Ogoh, Toshio Watanabe, Chikashi Ishioka, Natsuko Chiba
BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number. Molecular cancer research : MCR 16 (10) (2018)